コンテンツへスキップ
Merck

C1374

Sigma-Aldrich

CDK6/サイクリンD1, 活性型, His/GSTタグ付加 ヒト

PRECISIO® Kinase, recombinant, expressed in baculovirus infected Sf9 cells, ≥70% (SDS-PAGE), buffered aqueous glycerol solution

別名:

BCL1, CDK6, D11S287E, MGC59692, PLSTIRE, PRAD1, U21B31

ログイン組織・契約価格を表示する


About This Item

UNSPSCコード:
12352200
NACRES:
NA.32

リコンビナント

expressed in baculovirus infected Sf9 cells

品質水準

製品種目

PRECISIO® Kinase

アッセイ

≥70% (SDS-PAGE)

形状

buffered aqueous glycerol solution

比活性

7.9-10.7 nmol/min·mg

分子量

CDK6 subunit ~40 kDa
cyclin D1 ~61 kDa

テクニック

activity assay: suitable

溶解性

soluble
water: soluble

UniProtアクセッション番号

輸送温度

dry ice

保管温度

−70°C

遺伝子情報

詳細

Research area: APOPTOSIS

This recombinant product was expressed by baculovirus in Sf9 insect cells using an N-terminal His-tag on CDK6, and a GST-tag on Cyclin D1.

アプリケーション

CDK6/CyclinD1, active, His/GST tagged human has been used in: In vitro CDK6 activity assay to evaluate the effects of small-molecule inhibitors for therapeutic haematopoietic stem cells (HSC) expansion.

生物化学的/生理学的作用

Cyclin Dependent Kinases6 (CDK6) is a member of the cyclin-dependent family of protein kinases that are important regulators of cell cycle progression. CDK6 activity is regulated by the D-type cyclins and members of the INK4 family of CDK inhibitors. CDK6 kinase activity is detected during the mid-G1 phase of the cell cycle. It plays a crucial role in phosphorylating and regulating the activity of the retinoblastoma (RB), a tumor suppressor protein. Moreover, CDK6 has active involvement during transcription in hematopoietic stem cells (HSC) and tumor cells. Although CDK6 and CDK4 can both phosphorylate multiple residues in the Rb protein, they do so with different residue selectivity in vitro; CDK6 phosphorylates Thr821 while CDK4 phosphorylates Thr826 on Rb protein. The activation of cyclin D1-dependent kinase activity is found to be necessary to trigger the process of apoptosis.

物理的形状

50 mMリン酸ナトリウム(pH 7.0, 300 mM NaCl, 150 mMイミダゾール, 0.1 mM PMSF, 0.2 mM DTT, 25%グリセロール含有)。

法的情報

PRECISIO is a registered trademark of Merck KGaA, Darmstadt, Germany

保管分類コード

10 - Combustible liquids

WGK

WGK 1

引火点(°F)

Not applicable

引火点(℃)

Not applicable


適用法令

試験研究用途を考慮した関連法令を主に挙げております。化学物質以外については、一部の情報のみ提供しています。 製品を安全かつ合法的に使用することは、使用者の義務です。最新情報により修正される場合があります。WEBの反映には時間を要することがあるため、適宜SDSをご参照ください。

カルタヘナ法

カルタヘナ法

Jan Code

C1374-BULK:
C1374-VAR:
C1374-10UG-PW:
C1374-10UG:


試験成績書(COA)

製品のロット番号・バッチ番号を入力して、試験成績書(COA) を検索できます。ロット番号・バッチ番号は、製品ラベルに「Lot」または「Batch」に続いて記載されています。

以前この製品を購入いただいたことがある場合

文書ライブラリで、最近購入した製品の文書を検索できます。

文書ライブラリにアクセスする

Tohru Takaki et al.
Journal of biochemistry, 137(3), 381-386 (2005-04-06)
D-type cyclin-dependent kinases (Cdk4 and Cdk6) regulate the G1 to S phase progression of the mammalian cell cycle. It has been suggested that Cdk4 and Cdk6 may have distinct functions in vivo, even though they are indistinguishable biochemically. Here we
M Meyerson et al.
Molecular and cellular biology, 14(3), 2077-2086 (1994-03-01)
A family of vertebrate cdc2-related kinases has been identified, and these kinases are candidates for roles in cell cycle regulation. Here, we show that the human PLSTIRE gene product is a novel cyclin-dependent kinase, cdk6. The cdk6 kinase is associated
Haizhen Wang et al.
Nature, 546(7658), 426-430 (2017-06-14)
D-type cyclins (D1, D2 and D3) and their associated cyclin-dependent kinases (CDK4 and CDK6) are components of the core cell cycle machinery that drives cell proliferation. Inhibitors of CDK4 and CDK6 are currently being tested in clinical trials for patients
Yingdai Gao et al.
Nature communications, 6, 6328-6328 (2015-02-19)
Among cyclin-dependent kinase inhibitors that control the G1 phase in cell cycle, only p18 and p27 can negatively regulate haematopoietic stem cell (HSC) self-renewal. In this manuscript, we demonstrate that p18 protein is a more potent inhibitor of HSC self-renewal

ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.

製品に関するお問い合わせはこちら(テクニカルサービス)